Developing Medicines for Infectious Diseases
60° Pharmaceuticals (60P) continues to fulfill its promise of developing medicines for infectious diseases. Such diseases include COVID-19, babesiosis, fungal diseases, malaria, and dengue fever.* Despite competitive drug development pipelines for these diseases, critical gaps remain.
*ARAKODA has not been reviewed or approved by the U.S. Food and Drug Administration for the treatment or prevention of COVID-19, babesiosis, or fungal diseases.